[Adjuvant therapy of colonic carcinoma--soon in tablet form].
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000009:adverse effects; D000069287:Capecitabine; D017024:Chemotherapy, Adjuvant / Q000451:nursing*; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000451:nursing*; D003841:Deoxycytidine / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*; D018572:Disease-Free Survival; D005472:Fluorouracil / Q000031:analogs & derivatives; D006801:Humans; D015337:Multicenter Studies as Topic; D011355:Prodrugs / Q000008:administration & dosage* / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D013607:Tablets; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D011355:Prodrugs; D013607:Tablets; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil